http://www.bellicum.com
Bellicum Pharmaceuticals, Inc. Company Intro
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.
Industry
Healthcare
Bellicum Pharmaceuticals, Inc. Headquaters
Life Science Plaza
Houston,77030
United States
Bellicum Pharmaceuticals, Inc. Share price
14 Sep 2022 08:46 GMT
$1.4000
0.0 (0.0 %)
Bellicum Pharmaceuticals, Inc. Market cap
$11.641 M
WMC RANKING
2023
Bellicum Pharmaceuticals, Inc. # 293
BiotechnologyLatest Bellicum Pharmaceuticals, Inc. News
29 Mar 2023
StockNews.com Begins Coverage on Bellicum ...
Bellicum Pharmaceuticals, Inc is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and...
29 Mar 2023
Personalized Gene Therapy Treatments for Cancer Market ...
Top Key Players Covered Are: Amgen, Inc., SynerGene Therapeutics, Inc., ... Ltd., Cold Genesys, Inc., Takara Bio, Inc., Bellicum Pharmaceuticals, Inc.,...
29 Mar 2023
Wall Street analysts' outlook for Bellicum Pharmaceuticals Inc ...
Bellicum Pharmaceuticals Inc. (NASDAQ: BLCM) stock fell -1.89% on Tuesday to $0.26 against a previous-day closing price of $0.26.
WMC Market Score
WMC Market to Revenue Score
Bellicum Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Bellicum Pharmaceuticals, Inc. | USD | $500 | $48,900 | $-24,481 | $116M | 293 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Bellicum Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Bellicum Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Bellicum Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Bellicum Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Bellicum Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Bellicum Pharmaceuticals, Inc. | 0.01 | 3.91 | 0.00 | 0 | 0 | 0 | 1.76 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
